Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Titel:
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Auteur:
Corrie, P.G. Marshall, A. Nathan, P.D. Lorigan, P. Gore, M. Tahir, S. Faust, G. Kelly, C.G. Marples, M. Danson, S.J. Marshall, E. Houston, S.J. Board, R.E. Waterston, A.M. Nobes, J.P. Harries, M. Kumar, S. Goodman, A. Dalgleish, A. Martin-Clavijo, A. Westwell, S. Casasola, R. Chao, D. Maraveyas, A. Patel, P.M. Ottensmeier, C.H. Farrugia, D. Humphreys, A. Eccles, B. Young, G. Barker, E.O. Harman, C. Weiss, M. Myers, K.A. Chhabra, A. Rodwell, S.H. Dunn, J.A. Middleton, M.R.